tert-Butyl 2-(3-oxoisoindolin-4-yl)-1H-pyrrole-1-carboxylate

Catalog No. :
ACNMCJ299
CAS No. :
935269-07-1
Molecular Formula :
C17H18N2O3
Molecular Weight :
298.34

IUPAC Name:tert-butyl 2-(3-oxoisoindolin-4-yl)-1H-pyrrole-1-carboxylate

tert-Butyl 2-(3-oxoisoindolin-4-yl)-1H-pyrrole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$448.00Login to see priceInquiryInquiry
1g95%$1123.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(3-oxoisoindolin-4-yl)-1H-pyrrole-1-carboxylate
IUPAC Nametert-butyl 2-(3-oxoisoindolin-4-yl)-1H-pyrrole-1-carboxylate
MDL No.MFCD13183578
Molecular FormulaC17H18N2O3
Molecular Weight298.34
SMILESO=C(N1C(C2=CC=CC(CN3)=C2C3=O)=CC=C1)OC(C)(C)C
InChI KeyQELZOHKRDXZRSN-UHFFFAOYSA-N
Synonym1H-Pyrrole-1-carboxylic acid, 2-(2,3-dihydro-3-oxo-1H-isoindol-4-yl)-, 1,1-diMethylethyl ester;tert-Butyl 2-(3-oxoisoindolin-4-yl)-1H-pyrrole-1-carboxylate;tert-Butyl 2-(3-oxo-2,3-dihydro-1H-isoindol-4-yl)-1H-pyrrole-1-carboxylate
CAS No.935269-07-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACNMCJ299 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZJTE715 route compound structure diagram
    ACZJTE715135884-31-0 In Stock
  2. Plus
  3. ACRPHZ241 route compound structure diagram
    ACRPHZ241200049-46-3 In Stock
  4. Then
  5. ACNMCJ299 route product structure diagram
    ACNMCJ299935269-07-1
Inquiry

2. ACNMCJ299 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNMCJ299 route product structure diagram
    ACNMCJ299935269-07-1
Inquiry

Comments (0)